-
1. Pfizer: One of the world's premier biopharmaceutical companies
Link: https://www.pfizer.com/
Description: Web ResultPfizer Sets New Ambition: Changing a Billion Lives a Year by 2027. An evolution of the previous Purpose Blueprint, implemented in 2019, the Purpose Blueprint 2.0 consists of five “Core Business Principles” and 15 Big Ideas that will drive us in the years to come. Learn More About Our Blueprint 2.0
-
2. Pfizer - Wikipedia
Link: https://en.wikipedia.org/wiki/Pfizer
Description: Web ResultPfizer Inc. (/ ˈ f aɪ z ər / FY-zər) is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer (1824–1906) and his cousin Charles F. Erhart (1821–1891).
-
3. Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives …
Link: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-biontech-covid-19-vaccine-comirnatyr-receives-full
Description: Web ResultDec 11, 2020 · Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval for Individuals 16 Years and Older. COMIRNATY is the first COVID-19 vaccine to be granted FDA approval. Approval is based on a comprehensive submission package including six-month efficacy and safety data …
-
4. Coronavirus COVID-19: Vaccine, Drug and Treatment Updates - Pfizer
Link: https://www.pfizer.com/science/coronavirus/updates
Description: Web ResultFind a Trial. Areas of Focus. Rare Disease Smaller populations but big impact. Internal Medicine Extending lifespans worldwide. Inflammation & Immunology Treatment at the molecular level. Vaccines Preventing the spread of infections. Oncology The science of optimism. Anti Infectives Combatting an evolving risk. …
-
5. FDA Approves First COVID-19 Vaccine | FDA
Link: https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine
Description: Web ResultAug 23, 2021 · Inquiries. FDA approved the first COVID-19 vaccine, which has been known as the Pfizer-BioNTech COVID-19 Vaccine, and is now marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID...
-
6. Pfizer-BioNTech COVID-19 Vaccine | FDA
Link: https://www.fda.gov/vaccines-blood-biologics/coronavirus-covid-19-cber-regulated-biologics/pfizer-biontech-covid-19-vaccine
Description: Web ResultSep 11, 2023 · The Pfizer-BioNTech COVID-19 Vaccine, Bivalent is no longer authorized for use in the United States. Pfizer-BioNTech COVID-19 Vaccine (2023-2024 Formula) is authorized for use as follows ...
-
7. FDA Authorizes Booster Dose of Pfizer-BioNTech COVID-19 …
Link: https://www.fda.gov/news-events/press-announcements/fda-authorizes-booster-dose-pfizer-biontech-covid-19-vaccine-certain-populations
Description: Web ResultSep 22, 2021 · On Aug. 25, 2021, the FDA received a supplement from Pfizer Inc. to their biologics license application for Comirnaty seeking approval of a single booster dose to be administered approximately six ...
-
8. Pfizer–BioNTech COVID-19 vaccine - Wikipedia
Link: https://en.wikipedia.org/wiki/Pfizer%E2%80%93BioNTech_COVID-19_vaccine
Description: Web ResultMedical uses. The Pfizer–BioNTech COVID-19 vaccine is used to provide protection against COVID-19, caused by infection with the SARS-CoV-2 virus, by eliciting an immune response to the S antigen. [1] [2] [28] [37] The vaccine is used to reduce morbidity and mortality from COVID-19.
-
9. How Pfizer Makes Its Covid-19 Vaccine - The New York Times
Link: https://www.nytimes.com/interactive/2021/health/pfizer-coronavirus-vaccine.html
Description: Web ResultApr 28, 2021 · Pfizer and BioNTech are developing and testing new versions of their vaccine against recent variants, and might eventually alter their genetic recipe to mass-produce Covid-19 vaccines that target ...
-
10. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Link: https://www.nejm.org/doi/full/10.1056/NEJMoa2034577
Description: Web ResultDec 10, 2020 · Discussion. A two-dose regimen of BNT162b2 (30 μg per dose, given 21 days apart) was found to be safe and 95% effective against Covid-19. The vaccine met both primary efficacy end points, with ...